[Recap] STADA ON | STADA Pymepharco joins hands with healthcare professionals across Central Vietnam to promote the role of high-quality Generics in chronic disease management

From Dak Lak, Khanh Hoa to Quang Ngai, the STADA ON Scientific Seminar series – recently hosted by @STADA Pymepharco – brought together 200+ pharmacies in the Central provinces, featuring in-depth discussions led by Assoc. Prof. Dr. Truong Van Tuan – Standing Vice Chairman of the Ho Chi Minh City Pharmaceutical Association (HCPA).

The events focused on the importance of EU-GMP and Bioequivalence (BE) as two of the most stringent and essential global standards defining high-quality Generics. EU-GMP certified and bioequivalent generics are recognized for their consistent quality, safety, and therapeutic efficacy. These standards not only give healthcare professionals (HCPs) and pharmacies greater confidence in prescribing and dispensing but also ensure affordable treatment options suitable for long-term management of chronic diseases.

As the sole wholly-owned affiliate of @STADA Group (Germany) in Vietnam, STADA Pymepharco proudly delivers #GermanStandard medicines, manufactured on EU-GMP certified production lines at our two sites in Tuy Hoa (Dak Lak). Combining world-class quality with affordable access for Vietnamese patients, we continue exporting globally to stringent markets such as the EU, while fulfilling our purpose of “Caring for people’s health as a trusted partner”.

Beyond scientific discussions, the series offered a closer look at STADA Pymepharco’s diverse prescription portfolio, spanning antibiotics, cardiovascular, diabetes, anti-infective, anti-fungal, liver health, gastrointestinal, neurological, and anti-parasitic therapies– while fostered an open & engaging dialogue between pharmacies, experts, and the company.

💬 Participants praised the professional organization, practical content, and diverse product portfolio of STADA Pymepharco. Post-event surveys showed 100% satisfaction with the content and overall experience, while 53% expressed interest in more frequent scientific programs for continued learning.

These meaningful engagements further strengthen STADA Pymepharco’s partnership with HCPs – working together to enhance treatment quality and patient well-being.